We previously reported that both the nuclear import rate of large karyophilic gold particles and the functional size of the pores are significantly greater in simian virus 40-transformed fibroblasts (the SV-T2 cell line) than in nontransformed BALB/c 3T3 cells. In this study, we found that cytosolic fractions obtained from SV-T2 cultures can increase nuclear transport capacity (both import rate and pore size) when microinjected into BALB/c 3T3 cells. The transport-enhancing function of the extracts can be abolished by the protein kinase inhibitors staurosporine and K252a as well as 5-p-fluorosulfonylbenzoyladenosine and protein phosphatase 2A, which, although less specific, also interfere with kinase activity. Increases in transport capacity of the same magnitude as that produced by the SV-T2 extracts were obtained by microinjecting protein kinase A or C or recombinant mitogen-activated protein kinase. These data provide further support for the interpretation that the enhancer is a protein kinase. From experiments performed with specific kinase inhibitor peptides, it appears likely that protein kinase C is the active factor in the SV-T2 cytosolic fractions; however, this will require further verification. It was also determined, by using gold particles coated with bovine serum albumin conjugated to synthetic nuclear localization signal peptides that lacked phosphorylation sites, that the enhancer affects the transport machinery rather than the activity of the nuclear localization signals.
Regulating macromolecular exchanges between the nucleus and cytoplasm can serve as an effective method of modulating overall cellular activity. There are two basic methods by which the signal-mediated exchange processes can be controlled. One is dependent on the specific properties of the permeant molecule and is highly selective. This form of regulation is accomplished by either blocking access to the nuclear pores (by intracellular binding) or masking the nuclear localization signal (NLS). Examples of specific proteins whose intracellular distribution is regulated in this way include the catalytic subunit of cyclic AMP (cAMP)-dependent protein kinase (34, 35) , the NF-B/Rel/dorsal transcription factors (19, 20) , steroid receptors (32, 38) , and the cell cycle-dependent yeast transcription factor SWI5 (31) . A second method is dependent on modifications of the transport machinery and would have a more general effect on nucleocytoplasmic interactions. These modifications could involve changes in either the cytoplasmic NLS-binding factors or the translocation apparatus located within the pore complex.
One experimental approach used to investigate overall changes in transport capacity as a function of cellular activity involves the cytoplasmic injection of colloidal gold particles and subsequent electron microscopic (EM) analysis of particle uptake into the nucleus (9) . By coating different-sized particles with karyophilic proteins (e.g., nucleoplasmin), it is possible to assay both the relative rate of signal-mediated nuclear import and the functional size of the transport channel. With this method, nuclear transport capacity (both rates and channel size) was found to decrease as proliferating BALB/c 3T3 cells entered a period of growth arrest (10) . Cell fusion experiments indicated that the reduction in import was due to changes in the properties of the nuclear pores (11) . In contrast to the results obtained with quiescent cells, the nuclear import of nucleoplasmin-coated gold (NP-gold) was significantly greater after simian virus 40 (SV40) transformation of BALB/c cells than in normal proliferating populations (13) . The relative import rate of large particles (110 to 320 Å [1 Å ϭ 0.1 nm] in diameter, including the 30-Å protein coat) increased two-to threefold, and the functional pore diameter increased by approximately 40 Å, from about 240 to 280 Å. Theoretically, these changes could contribute to the establishment and maintenance of the transformed state by increasing (i) the nuclear export of large ribonucleoprotein particles (e.g., ribosomal subunits), which could, in turn, facilitate protein synthesis and cell growth, and (ii) the import of proteins (or perhaps protein aggregates) necessary for nucleic acid synthesis.
The main focus of this study was to identify the factor(s) responsible for the increased transport capacity observed in SV40-transformed cells. In an earlier investigation, it was determined that the cytoplasmic injection of large T antigen, a product of the early SV40 gene, caused an increase in nuclear permeability of the same magnitude as observed in transformed cells (13) . The transport increase occurred between 1 and 6 h postinjection and was dependent on the nuclear localization of the T antigen. Thus, a mutant of large T which remains in the cytoplasm following injection did not affect nuclear import; however, when the same mutant was introduced directly into the nucleus, transport increased significantly (12) . The delayed effect, plus the requirement for nuclear localization, indicates that large T does not react directly with the cytoplasmic transport machinery but functions by modulating the activity of an effector molecule. Data suggesting that p53 might serve as an intermediate in this process were also obtained (12) .
To investigate the nature of the transport enhancer, an experimental system was first established by demonstrating that cytosolic extracts from SV-T2 cells (an SV40-transformed cell line) retained transport-enhancing activity. It was then determined that this activity could be blocked by treating the extracts with agents that would be expected to inhibit kinase activity. Furthermore, the same increase in nuclear import produced by the extracts could be obtained by cytoplasmic injection of purified kinases. Taken together, these results argue that the transport increase is initiated by a protein kinase(s). The use of more specific inhibitors identified protein kinase C (PKC) as a probable enhancing factor. It was also found that the enhancer alters transport capacity by acting on one or more components of the transport apparatus rather than on the permeant (signal-containing) protein.
MATERIALS AND METHODS
Reagents. The general kinase inhibitors staurosporine and K252a were purchased from Calbiochem (San Diego, Calif.). Stock solutions of staurosporine (100 M) and K252a (214 M) were made up in dimethyl sulfoxide (DMSO) and dimethylformamide (DMF), respectively, and stored at Ϫ20ЊC. 5Ј-p-Fluorosulfonylbenzoyladenosine (FSBA) was obtained from Sigma (St. Louis, Mo.). Fresh stock solutions containing 50 mM FSBA in DMSO were mixed prior to each experiment. The synthetic peptide inhibitors for PKA (TYADFIASGRTGRR NAI) and PKC (RFARKGALRQKNV) were purchased from Upstate Biotechnology (Lake Placid, N.Y. Cell cultures. BALB/c 3T3 A31 cells and an SV40-transformed BALB/c 3T3 cell line designated SV-T2 were obtained from the American Type Culture Collection (Rockville, Md.). Both cell lines were cultured in 5% CO 2 at 37ЊC in Dulbecco's modified Eagle's medium containing 4 mM glutamine and glucose (4.5 mg/ml). The medium was supplemented with 10% calf serum plus 100 U of penicillin G, 100 g of streptomycin, and 2.5 g of amphotericin B (Fungizone) per ml. All of the culture reagents were purchased from GIBCO/BRL (Gaithersburg, Md.).
Nuclear transport assays were performed on BALB/c 3T3 or SV-T2 cells that had been plated on gridded ACLAR coverslips (Allied Corp., Morristown, N.J.) approximately 24 h earlier. The use of ACLAR greatly simplified later EM analysis, as described in reference 9.
The SV-T2 and BALB/c 3T3 cells that were used to obtain cytoplasmic extracts were cultured in 100-mm petri dishes. Twenty dishes of SV-T2 cells, which were allowed to grow to confluence, yielded approximately 1 ml of packed cells after low-speed centrifugation. Since there is a significant change in nuclear transport capacity when BALB/c 3T3 cells become quiescent (10) , these cells were collected after reaching only 75% confluence. At this density, 40 dishes yielded approximately 0.5 ml of packed cells.
Preparation of cytosolic extracts. Cytosolic extracts were prepared by a procedure similar to that described by Adam et al. (1) . Packed SV-T2 cells (1 ml) or packed BALB/c 3T3 cells (0.5 ml) were rinsed in PBS by resuspension and low-speed centrifugation. The cells were then suspended in an equal volume of lysis buffer, which contained 5 mM HEPES (N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid, pH 7.3), 10 mM potassium acetate, 2 mM magnesium acetate, 2 mM DTT, 20 M cytochalasin B, 0.1 mM phenylmethylsulfonyl fluoride (PMSF), and pepstatin, leupeptin, and aprotinin (1 g/ml each). After 10 min on ice, the cells were lysed in a 2-ml Dounce homogenizer and centrifuged at 16,000 ϫ g for 15 min. The supernatant was further centrifuged at 100,000 ϫ g for 60 min and dialyzed against extract buffer (EB), which consisted of 120 mM KCl, 10 mM NaCl, 1 mM magnesium acetate, 1 mM DTT, 6 mM K 2 HPO 4 , 4 mM KH 2 PO 4 (pH 7.0), 0.1 mM PMSF, and pepstatin, leupeptin, and aprotinin (1 g/ml each). Finally, the extracts were aliquoted and stored at Ϫ80ЊC. At this temperature, activity was retained for at least 2 weeks. The protein concentration of the extracts ranged from 11 to 18 mg/ml, as determined by the Bradford assay procedure (5), with BSA as a standard. Prior to microinjection, all extracts were centrifuged at 100,000 ϫ g for 15 min in a Beckman Airfuge to remove particulate material.
Nuclear transport reporters. Nuclear transport was assayed by using colloidal gold particles coated with either nucleoplasmin or BSA conjugated with synthetic peptides containing the SV40 large T nuclear localization signal (BSA-NLS conjugates).
Colloidal gold fractions with particles ranging from 20 to 50 Å in diameter were prepared by reducing gold chloride with a saturated solution of phosphorus in ether (8) . To obtain larger particles, 80 to 290 Å in diameter, sodium citrate was used as a reducing agent (14) .
Nucleoplasmin was isolated from Xenopus oocytes as described by Dworetzky et al. (7) . A peptide, CGGGPKKKRKVGG, containing the large T NLS (underlined) (25) was synthesized by the University of Florida protein core facility and covalently bound to BSA through the cysteine residue by using the bifunctional cross-linker m-maleimidobenzoyl-N-hydroxysuccinimide ester (27) . The peptide-to-signal ratio was approximately 8, as determined by SDS-polyacrylamide gel electrophoresis (PAGE). The gold particles were coated with protein (nucleoplasmin or BSA conjugates) as outlined by Dworetzky et al. (7) . The protein coat increased the overall particle diameter by about 30 Å. Prior to microinjection, the coated gold preparations were dialyzed against intracellular medium (117 mM KCl, 10 mM NaCl, 6 mM K 2 HPO 4 , 4 mM KH 2 PO 4 [pH 7.0]).
Microinjection and EM. The procedures for microinjection and EM have been described in detail in a previous report (9) . Briefly, microinjections were performed at 37ЊC in an enriched CO 2 atmosphere, using a continuous-flow injection system. For EM, cells were fixed in 1% glutaraldehyde, postfixed in OsO 4 , and examined with a JEOL 100CX microscope.
RESULTS
Effect of cytosolic extracts on nuclear transport. Initially, we determined the effects of cytosolic extracts obtained from transformed (SV-T2) and nontransformed (BALB/c 3T3) cells on nuclear import. Extracts were injected into the cytoplasm of normal, proliferating BALB/c 3T3 cells in amounts equivalent to approximately 5% of the total cell volume. After 5 to 10 min, the cells were injected for a second time with large NP-gold (110 to 320 Å in diameter, including the protein coat) and fixed 30 min later for EM analysis. The relative rate of gold import into the nucleus was obtained from electron micrographs by counting particles in equal and adjacent areas of nucleoplasm (N) and cytoplasm (C) and determining the N/C gold ratio. The functional size of the nuclear pores was established by measuring the diameters of the particles that had entered the nucleoplasm. These results are expressed as the percentage of particles having diameters above and below 200 Å. This cutoff point was chosen because it closely approximates the exclusion limit for nuclear import in normal BALB/c 3T3 cells. In these and all subsequent experiments, NP-gold import was also measured in untreated cells (referred to in the tables as BALB/c controls) to correct for possible differences in the NP-gold preparations and/or culture conditions. The sizes of the particles that were available for transport were determined by analyzing the dimensions of the gold injected into the cytoplasm (referred to as cytoplasmic gold size). A comparison of the data obtained for the transformed and nontransformed cell extracts is shown in Table 1 . Injection of SV-T2 cytosolic fractions resulted in statistically significant increases in both the nuclear import rate and pore size, demonstrating that transport-enhancing activity is not lost during the extraction procedure. In contrast, BALB/c 3T3 fractions had no effect on NPgold import. The protein concentrations of the injected fractions ranged from 11 to 18 mg/ml. Significant increases in transport were also obtained at a concentration of 4 mg/ml but not at 0.8 mg/ml (data not shown).
To determine if the factor(s) present in active cytosolic fractions can fully account for the nuclear transport changes that occur during transformation, the import of large NP-gold was compared in SV-T2 cells and BALB/c cells injected with extracts. It can be seen in Table 2 that in both cases, nuclear import was significantly greater than in untreated BALB/c controls; however, the two experimental groups were not significantly different from each other (N/C ratio, P ϭ 0.067; particle size, P ϭ 0.44). These results indicate that all of the enhancing activity is retained in the soluble cytosolic fraction and that insoluble components are not involved.
Since it was previously found in BALB/c cells that changes in the nuclear uptake of NP-gold that accompany changes in 7044 FELDHERR AND AKIN MOL. CELL. BIOL.
on June 30, 2017 by guest http://mcb.asm.org/ cellular activity can be size dependent (10), the effect of SV-T2 extracts on the import rates (N/C ratios) of small and large NP-gold fractions (50 to 80 and 110 to 320 Å in diameter, respectively, including the protein coat) were compared. As can be seen in Table 3 , the enhancing factor did not alter the nuclear uptake rate of the small gold but did result in an increase of more than threefold in the N/C ratio of the large fraction (also see Tables 1 and 2 ). In an earlier investigation (13) , it was established that following microinjection, small and large particles have equal access to the nuclear pores in both BALB/c 3T3 and SV-T2 cells; therefore, it is unlikely that the present results were due to differential migration of the two gold fractions in the cytoplasm. One plausible explanation for the increased import of large gold is that the transformed cell extract acts primarily by altering the functional size of the pores. This would be consistent with the interpretation that the same number of pores are active in the transport of small particles in both treated and untreated cells but, in the presence of an SV-T2 extract, there is an increase in the proportion of pores that are also capable of transporting larger particles. Earlier results obtained with purified large T antigen (13) argue against the possibility that the enhancing activity of the SV-T2 extracts is due simply to the retention of large T antigen. When T antigen was injected at a concentration of 0.65 mg/ml, which can be easily observed by immunofluorescence, there was at least a 1-h delay before an increase in nuclear transport was detected. Transformed cell extracts, on the other hand, cause an increase within 10 min, and large T was not present in sufficient amounts to be detected by immunofluorescence. It is also unlikely that the SV-T2 enhancer is a known cytoplasmic transport factor (e.g., importin, p97, Ran/TC4, or NTF2; see reviews by Melchior and Gerace [29] and Powers and Forbes [39] ). This would be the case if one or more of these factors was rate limiting and produced in larger amounts following transformation. However, it is doubtful that sufficient material was injected in the present experiments (5% of the cell volume, and protein concentrations as low as 4 mg/ml) to significantly increase the concentration of any of the known transport factors. Overall, the data are more consistent with the view that the SV-T2 enhancer has a catalytic effect, raising the possibility that it is a kinase.
Effect of kinase inhibitors on enhancing activity. To determine if phosphorylation is involved in enhancing transport activity, cytosolic extracts from transformed cells were treated with agents that would be expected to block kinase activity. In these experiments, BALB/c 3T3 cells were first injected with either treated or untreated extracts followed 5 to 10 min later by an injection of NP-gold to measure transport capacity. When the inhibitors are known to react reversibly with kinases, the cells were also treated with inhibitor (at the same concentrations used in the extracts) for 30 min before and during the course of the experiments. The same protocol was used to study the effects of the inhibitors alone except that the inhibitors were added to EB solution rather than extract for the initial injections. Transport data were also obtained for untreated cells (BALB/c controls, injected only with NP-gold).
The following reagents were used: staurosporine (30 nM) and K252a (50 nM), which are both general kinase inhibitors (26, 36, 44) ; FSBA (0.5 mM), an ATP analog which reacts covalently with a lysine residue located within the ATP-binding domain of a number of enzymes, including protein kinases (3, 37); and PP-2A (1 M) (21), which would be expected to neutralize the action of kinases that might be involved in modulating transport. Staurosporine and K252a were added to the extracts 45 min before microinjection (including the 15-min centrifugation period), and since binding of these inhibitors is reversible, the cells were also treated. To optimize the effect of FSBA, it was necessary to dialyze the extracts used in these experiments against modified EB solution (120 mM KCl, 10 mM NaCl, 10 mM MgCl, 1 mM EDTA, 50 mM Tris [pH 7.0], and protease inhibitors as described above). FSBA was added to the extracts for 30 min, at which time unbound reagent was removed by dialysis at 4ЊC for 4 h. PP-2A (a 1:10 dilution of the stock solution) was added to the extract just before injection. In control experiments, the effects of 1 M PP-2A in EB solution (in the absence of extract) and a 1:10 dilution of PP-2A solubilization medium (see Materials and Methods) in extract were tested. 
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The results in Table 4 (experiments A and B) show that staurosporine and K252a prevented the increases in relative nuclear import and functional pore size, respectively, that are induced by SV-T2 cytosolic extracts. The inhibitors alone had no significant effect on the basal transport level. Similarly, FSBA inhibited the enhancing activity of the extracts (Table 4 , experiment C). In control experiments, it was determined that DMSO, equal to the amount present in the FSBA stock solution that was added to the extract, and subsequent 4 h of dialysis did not inactivate the extracts (data not shown). The activity of the extracts was also blocked by the simultaneous injection of PP-2A (Table 4 , experiment D). This result was due specifically to PP-2A and not to other components of the stock solution. Furthermore, the injection of PP-2A alone did not alter basal transport capacity.
Effect of purified kinases. If the transport-enhancing activity in SV-T2 cells is dependent on phosphorylation, as suggested by the inhibitor studies, it is reasonable to expect that purified kinases would also increase nuclear import. This would not only support the proposal that the enhancing factor is a kinase but could be a useful first step in identifying the specific kinase(s) involved. To test the direct effect of kinases, 25 nM PKA (28), 3.5 nM PKC (43), 12.8 nM GST-p42 (18), 8.8 nM CK-1 (33), or 23 nM CK-2 (33) was injected into the cytoplasm of BALB/c 3T3 cells. Five to 10 min later, NP-gold was injected, and nuclear import was assayed by EM. The kinase concentrations used in these experiments are based on previous studies that also involved microinjection into living cells (references given above) and are 20-to 100-fold lower than the amounts recommended for in vitro assays. The final concentrations were obtained by diluting the PKA, PKC, GST-p42, CK-1, and CK-2 stock solutions 50-, 100-, 125-, 40-, and 20-fold, respectively, in intracellular medium. To determine if components of the stock solutions other than kinases could affect transport, the same experiments (at the same dilutions) were performed with the PKA, PKC, and GST-p42 solubilization medium alone (see Materials and Methods for composition).
It can be seen in Table 5 that PKA, PKC, and GST-p42 but not the casein kinases significantly increased nuclear import of NP-gold. The controls demonstrated that the transport increases were, in fact, caused by the kinases and not by other components of the injected solutions.
Effect of specific kinase inhibitors on nuclear import. The fact that PKA, PKC, and GST-p42 stimulate transport raises the possibility that one or more of these enzymes is the active enhancing factor in transformed cells. To test this proposal, the effects of specific peptide inhibitors of PKA (TYADFIAS-GRTGRRNAI [16] ) and PKC (RFARKGALRQKNV [22] ) were investigated. The PKA (K i ϭ 1.7 nM) and PKC (K i ϭ 0.2 M) inhibitors were added to SV-T2 cytosolic extracts at concentrations of 17 nM and 2 M, respectively. At this concentration, the PKC inhibitor has essentially no effect on PKA (42) . After a 30-min incubation period, the treated extracts were injected into BALB/c 3T3 cells; NP-gold was injected 5 to 10 min later. As seen in Table 6 , the PKC peptide inhibitor blocked the transport-enhancing activity of the extract. The PKA inhibitor, on the other hand, failed to suppress enhancing activity and was also ineffective when the concentration was increased from 17 to 200 nM (data not shown). In control experiments, the injection of 2 M PKC inhibitor in EB me- The enhancing factor affects the transport apparatus, not NLS activity. In view of the evidence that phosphorylation of serine and threonine residues adjacent to the NLS can significantly alter nuclear import rates (24, 40, 41, 45) , it was necessary to determine whether the enhancing factor acted by modifying the transport apparatus or by increasing the effectiveness of the nucleoplasmin NLSs. To distinguish between these two possibilities, experiments were performed in which the gold particles were coated with BSA conjugated with synthetic peptides that contained the large T NLS but no phosphorylation sites. The experimental protocol was as described above, i.e., SV-T2 extract or purified kinase (PKA) was injected followed by gold and subsequent EM analysis. The results (Table 7) were the same as those obtained when NP-gold was used as a reporter, demonstrating that (i) the enhancer acts at the level of the transport apparatus and (ii) the changes in nuclear import are not dependent on a specific type of NLS.
DISCUSSION
In this study, it was found that cytosolic extracts from SV40-transformed BALB/c cells can significantly increase signal-mediated nuclear import when injected into nontransformed cells. The transport-enhancing activity was blocked by treating the extracts with staurosporine or K252a, which are general kinase inhibitors, as well as FSBA and PP-2A, which, although less specific, also suppress or reverse phosphorylation. These results indicate that the enhancer is a kinase, an interpretation that was further supported by the finding that an increase in nuclear import similar to that induced by the extracts was obtained by injecting purified kinases. The fact that different kinases can enhance transport when microinjected could be coincidental (e.g., they might act by phosphorylating the same regulatory protein or by stimulating different pathways that can target a common substrate) and does not necessarily mean that they normally perform this function in transformed cells. By coating gold particles with karyophilic protein conjugates that lacked relevant phosphorylation sites, it was possible to demonstrate that the enhancing factor acted by altering the functional capacity of the transport machinery rather than the effectiveness of the NLSs.
The addition of a specific PKA inhibitor peptide to the SV-T2 cytosolic fraction had no effect on its activity; however, an increase in nuclear import was prevented when the extracts were treated with a PKC inhibitor. These results are consistent with the view that PKC is involved in modulating nuclear permeability in transformed cells. It should be kept in mind, however, that other kinases (including as yet unidentified enzymes) might also be sensitive to the PKC peptide inhibitor. For example, Smith et al. (42) reported that calcium/calmodulin-dependent protein kinase 2 is affected by the PKC inhibitor, although at the concentration used in this study, the decrease in calcium/calmodulin-dependent protein kinase 2 activity should have been less than 10%. Experiments in which extracts will be treated with antibodies against specific PKC isoenzymes are planned and should provide more definitive data regarding the possible involvement of PKC.
Aside from the well-documented effect of protein phosphorylation on NLS activity, there are several reports indicating that kinases are also required for the transport process itself. Mishra and Parnaik (30) found that treating permeabilized fibroblasts with alkaline phosphatase prevented nuclear transport of NLS-albumin conjugates and that transport could be restored by the addition of PKC or the catalytic subunit of PKA. Furthermore, these investigators identified two proteins of 60 to 62 kDa that could be substrates for the kinases. Vandromme et al. (46) studied the nuclear import of the myogenic factor MyoD in fibroblasts and determined that microinjection of the PKA inhibitor peptide blocked MyoD transport. Mutating the PKA-dependent phosphorylation sites on MyoD had no effect on transport, suggesting that phosphorylation occurred at the level of the transport apparatus. PKA activity is also required for the nuclear uptake of the serum response factor (p67 SRF /SRF) as well as a large T NLS-immunoglobulin G conjugate (15) . As observed for MyoD, phosphorylation affected the transport machinery rather than the permeant molecules.
It is of interest to compare the present results, which are concerned primarily with the regulatory function of kinases in transformed cells, with those relating to the intrinsic role of phosphorylation in nuclear import (summarized above). Such a comparison suggests that PKA has a constitutive function (although it has the capacity to enhance size-dependent transport when microinjected), whereas PKC is involved in regulation. This would indicate that the phosphorylation reactions that are involved in regulation and translocation target different components of the transport machinery. Differences were also observed in the effects of inhibitors on nuclear import. In contrast to the experiments discussed in the previous paragraph, we found that neither phosphatase (PP-2A) nor kinase inhibitors (staurosporine, K252a, PKC autoinhibitory peptide, or FSBA) affected basal transport levels in nontransformed cells. These findings, however, could simply be due to differences in the specific inhibitors used, the inhibitor concentrations, or the nature of the experimental systems.
At present, there is no information relating to the mode of action of the SV-T2 enhancing factor. It could act directly, by phosphorylating a component of the transport machinery, or indirectly, by activating an intermediary signaling pathway.
Since the enhancer increases the functional diameter of the pores, its ultimate target is likely to be the transporter element of the pore complex (2); however, modifications of cytoplasmic NLS-binding proteins cannot be ruled out. Consistent with the latter possibility, Azuma et al. (4) found that Spr1p, a yeast homolog of the Xenopus NLS-binding protein importin (17) , is phosphorylated by a novel protein kinase (Srp1p kinase); furthermore, the reaction is greatly stimulated by NLS-containing peptides. These results raise the possibility that phosphorylation plays a role in the NLS-binding step and might also function in regulation. Given the central role of PKC isoenzymes in signal transduction and their widespread distribution within cells, including the nuclear envelope (6, 23), they could plausibly function as enhancing factors in any of the above scenarios. 
